A statistically significantly increased risk of vitiligo was associated with the iNOS-954 (GC+CC) genotype compared with the -954 GG genotype, which was more pronounced among vitiligo patients with the following characteristics: non-segmental, active vitiligo and without other autoimmune diseases. Here, NOS2 is linked to autoimmune disease.